HF
AZN icon

HRT Financial’s AstraZeneca AZN Stock Holding History

HRT Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
10,334
-8,750
-46% -$1.65M ﹤0.01% 1768
2026
Q1 		$3.76M Buy
+19,084
New +$3.68M 0.01% 1169
2025
Q4 		– Sell
-85,818
Closed -$13.2M – 3172
2025
Q3 		$13.2M Buy
85,818
+34,706
+68% +$5.25M 0.05% 301
2025
Q2 		$7.14M Sell
51,112
-65,334
-56% -$9.16M 0.03% 404
2025
Q1 		$17.1M Buy
+116,446
New +$16.8M 0.11% 137
2024
Q4 		– Sell
-99,665
Closed -$15.5M – 2432
2024
Q3 		$15.5M Buy
99,665
+33,331
+50% +$5.38M 0.08% 166
2024
Q2 		$10.3M Buy
66,334
+25,183
+61% +$3.79M 0.06% 244
2024
Q1 		$5.58M Sell
41,151
-73,490
-64% -$9.73M 0.03% 236
2023
Q4 		$15.4M Buy
114,641
+105,978
+1,223% +$13.8M 0.11% 104
2023
Q3 		$1.17M Buy
8,663
+2,494
+40% +$341K 0.01% 887
2023
Q2 		$883K Buy
+6,169
New +$908K 0.01% 1022
2022
Q2 		– Sell
-5,746
Closed -$762K – 2919
2022
Q1 		$762K Sell
5,746
-501
-8% -$60.1K 0.01% 1241
2021
Q4 		$727K Sell
6,247
-104,309
-94% -$12.3M ﹤0.01% 1473
2021
Q3 		$13.3M Buy
+110,556
New +$12.9M 0.08% 118
2021
Q2 		– Sell
-22,276
Closed -$2.21M – 2836
2021
Q1 		$2.21M Buy
22,276
+17,532
+370% +$1.76M 0.02% 568
2020
Q4 		$474K Sell
4,744
-86,037
-95% -$9.11M 0.01% 1047
2020
Q3 		$9.95M Buy
+90,781
New +$10.1M 0.29% 61
2019
Q1 		– Sell
-2,734
Closed -$207K – 515
2018
Q4 		$207K Buy
+2,734
New +$213K 0.03% 476
2017
Q4 		– Sell
-3,253
Closed -$220K – 118
2017
Q3 		$220K Buy
+3,253
New +$206K 0.27% 66

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's AZN Position: Q2 2026 in Review

HRT Financial reduced its AstraZeneca (AZN) stake by 46% in Q2 2026, selling an estimated $1.65M and leaving 10,334 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

HRT Financial first reported a position in AZN in Q3 2017 and has held it in 19 quarters since. The position peaked at $17.1M in Q1 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • HRT Financial held 10,334 shares of AstraZeneca worth $1.96M as of Q2 2026.
  • HRT Financial sold 8,750 AstraZeneca shares in Q2 2026, an estimated $1.65M.
  • AstraZeneca made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1768 holding.
  • HRT Financial first reported a position in AstraZeneca in Q3 2017 and has held it in 19 quarters since.
  • HRT Financial's AstraZeneca position peaked at $17.1M in Q1 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.